Sound Healthcare Communications
Independent
Address
200 Crossing Blvd, 7th Floor
Bridgewater, New Jersey 8807
Web Address
Year Founded
2014
Full-time Employees
72
Number of Clients
21
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
1
Locations
200 Crossing Blvd, Bridgewater, NJ
Executives & Senior Management
Jeff Hack
Managing Partner, Creative
Ryan Perkins
Managing Partner, Client Services
Nick Rhodin
Managing Partner, Strategy
Senior Management
Jeff Hack
Managing Partner, Creative
Ryan Perkins
Managing Partner, Client Services
Nick Rhodin
Managing Partner, Strategy
Kristen Pilkiewicz
SVP, Creative Director
Christie Hayes
SVP, Director of Client Services
Kieran Gorman
SVP, Director of Strategic Planning
Lisa Eapen, PharmD
SVP, Director of Medical Strategy
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Payer
Med-Tech
Public Health
Data/Analytics
Digital
New Services
Omnichannel strategy: With the addition of Michael Pruskowski, SVP, Director of Omnichannel Strategy, we now have the ability to develop sophisticated and robust omnichannel tactical plans to help pull through our best-in-class brand strategy.
Client Roster
Boehringer Ingelheim - OFEV
Pfizer - Dostinex
Pfizer - Sayana
Pfizer - Pristiq
Pfizer - Somatrogon
Pfizer - Genotropin
Pfizer - Somavert
Pfizer - Benefix
Pfizer - Xyntha
Pfizer - Premarin tablets
Pfizer - Premarin vaginal cream
Pfizer - Estring
Sobi - Gamifant
Sobi - Kineret
Sobi - SEL-212
Apellis - Empaveli
AbbVie - Linzess
Antios - ATI-2173
AIS - Targeted drug delivery
Corium - Azstarys
Corium - Adlarity
Growth
2021 Growth from Existing Clients
70%
2021 Growth from New Clients
30%
Trends and Challenges
Talent acquisition/retention
Managing growth
Replenishing new-business pipeline
Shrinking pharma budgets
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Working from home
Creative Samples
